logo

Shariah compliance overview

Not Halal

Editas Medicine, Inc. (EDIT) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Editas Medicine, Inc.

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology.

Editas Medicine, Inc. (EDIT) operates in the Healthcare sector, in the Biotechnology industry.

Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing securities and assets.

Business Activity
25.81%Limit 5%Fail
Interest-bearing debt
18.33%Limit 30%Pass
Interest-bearing securities and assets
41.59%Limit 30%Fail
Dividend purification
25.81%Share of dividends to give to charityPurification calculator

Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Editas Medicine, Inc. (EDIT). Current Akinda screening label: Not Halal.